Concepedia

Publication | Open Access

A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis

DOIFull Paper Access

150

Citations

45

References

2012

Year

Paul Rutgeerts, Richard N. Fedorak, Daan W. Hommes, Andreas Sturm, Daniel C. Baumgart, Brian Bressler, Stefan Schreiber, John Mansfield, Marna Williams, Meina Tang,
Gut

Abstract

Etrolizumab is well tolerated in moderate to severe UC. Further investigation is warranted.

References

YearCitations

Page 1